Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome
- PMID: 26170011
- DOI: 10.1016/j.humpath.2015.05.010
Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome
Abstract
Triple-negative breast cancer (TNBC) is a heterogeneous group of disease with a well-known association with epithelial-mesenchymal transition (EMT) and breast cancer stem cell phenotype. Recent studies have shown that TNBC can be classified into 6 subtypes, including basal-like, mesenchymal-like, and mesenchymal stem-like subtypes. However, clinical significance of the EMT in TNBC remains unclear. We analyzed immunohistochemical expression of EMT-related markers, including EMT markers (expression of vimentin, smooth muscle actin, osteonectin, and N-cadherin; loss of E-cadherin), EMT inducers (ZEB1 and CD146), and breast cancer stem cell markers (CD44(+)/CD24(-) and aldehyde dehydrogenase 1) in 173 TNBCs and correlated their expression with clinicopathological features of the tumors, including clinical outcome. Expressions of vimentin, CD44(+)/CD24(-), and CD146 were more frequent in basal-like TNBCs than non-basal-like TNBCs. Whereas CD146 expression was closely associated with the expression of various EMT markers and CD44(+)/CD24(-) phenotype, ZEB1 expression correlated only with the expression of smooth muscle actin. Expressions of vimentin, smooth muscle actin, osteonectin, and ZEB1 and loss of E-cadherin were more frequently found in metaplastic carcinomas than in other histologic subtypes. In survival analyses, EMT markers were not associated with patients' clinical outcomes. However, ZEB1 expression was found to be an independent prognostic factor for poor disease-free survival. These findings indicate that expression of EMT-related markers in TNBCs can be a signature of a certain subgroup of TNBC, which is associated with metaplastic carcinoma, and ZEB1 expression can serve as a potential biomarker to define a subgroup of TNBC associated with poor clinical outcomes.
Keywords: CD146; Epithelial-mesenchymal transition; Metaplastic carcinoma; Triple-negative breast cancer; ZEB1.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
Prognostic value of microRNA-9 and microRNA-155 expression in triple-negative breast cancer.Hum Pathol. 2017 Oct;68:69-78. doi: 10.1016/j.humpath.2017.08.026. Epub 2017 Sep 4. Hum Pathol. 2017. PMID: 28882698
-
Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype.Breast Cancer Res Treat. 2013 Feb;138(1):81-90. doi: 10.1007/s10549-013-2442-0. Epub 2013 Feb 15. Breast Cancer Res Treat. 2013. PMID: 23412770
-
The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions.Hum Pathol. 2015 Jan;46(1):1-8. doi: 10.1016/j.humpath.2014.10.004. Epub 2014 Oct 16. Hum Pathol. 2015. PMID: 25455994
-
ZEB1: at the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance.Cell Cycle. 2015;14(4):481-7. doi: 10.1080/15384101.2015.1006048. Cell Cycle. 2015. PMID: 25607528 Free PMC article. Review.
-
Oncogenic functions of the EMT-related transcription factor ZEB1 in breast cancer.J Transl Med. 2020 Feb 3;18(1):51. doi: 10.1186/s12967-020-02240-z. J Transl Med. 2020. PMID: 32014049 Free PMC article. Review.
Cited by
-
Regulation of breast cancer metastasis signaling by miRNAs.Cancer Metastasis Rev. 2020 Sep;39(3):837-886. doi: 10.1007/s10555-020-09905-7. Cancer Metastasis Rev. 2020. PMID: 32577859 Free PMC article. Review.
-
miR-144 functions as a tumor suppressor in breast cancer through inhibiting ZEB1/2-mediated epithelial mesenchymal transition process.Onco Targets Ther. 2016 Oct 11;9:6247-6255. doi: 10.2147/OTT.S103650. eCollection 2016. Onco Targets Ther. 2016. PMID: 27785072 Free PMC article.
-
NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation.Nat Commun. 2020 Jun 26;11(1):3256. doi: 10.1038/s41467-020-16936-9. Nat Commun. 2020. PMID: 32591500 Free PMC article.
-
Correlation between High PD-L1 and EMT/Invasive Genes Expression and Reduced Recurrence-Free Survival in Blood-Circulating Tumor Cells from Patients with Non-Muscle-Invasive Bladder Cancer.Cancers (Basel). 2021 Nov 28;13(23):5989. doi: 10.3390/cancers13235989. Cancers (Basel). 2021. PMID: 34885101 Free PMC article.
-
Prognostic Significance of Zinc Finger E-Box-Binding Homeobox Family in Glioblastoma.Med Sci Monit. 2018 Feb 24;24:1145-1151. doi: 10.12659/msm.905902. Med Sci Monit. 2018. PMID: 29476046 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous